Orion Health, a global leader in population health software, is strengthening its position in North America with new technology and the appointment of James Rice as Executive Vice President for North America.
Orion Health strengthens North American operations with new technology and leadership Read More »
Biocept, Inc. announces enrollment of the first patient in the FORESEE clinical trial with the Company’s proprietary cerebrospinal fluid assay CNSide (NCT05414123).
Oncorus, Inc. today reported fourth quarter and full year 2022 financial results and provided an update on its business.
Leap Therapeutics, Inc. today reported financial results for the fourth quarter and year ended December 31, 2022.
Leap Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results Read More »
Ryvu Therapeutics reported financial results for the fourth quarter and the full year ended December 31, 2022, and provided a corporate update.
Humacyte, Inc. today announced financial results for the fourth quarter and year ended December 31, 2022, and highlighted recent corporate accomplishments.
Allarity Therapeutics, Inc. announced that it intends to effect a reverse stock split of its common stock, at a ratio of 1 post split share for every 35 pre-split shares.
Allarity Therapeutics Announces Reverse Stock Split of Common Stock Read More »
¿Está buscando los mejores servicios VPN para utilizar mientras esté en España en 2023? Con la creciente necesidad de asegurar las actividades en línea y proteger la información personal, las redes privadas virtuales (VPN) se han convertido en una herramient …
Evotec SE announced that the Company has received a US$ 6.6 m grant from The Bill & Melinda Gates Foundation for drug discovery in tuberculosis.
Evotec Receives US$ 6.6 m Grant for Drug Discovery in Tuberculosis Read More »
Royal Philips announced it has convened the Annual General Meeting of Shareholders 2023 and published the agenda with explanatory notes.
Philips convenes the Annual General Meeting of Shareholders 2023 Read More »
